ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 135 filers reported holding ANI PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,852 | +5.6% | 4,200 | -47.5% | 0.00% | – |
| Q1 2022 | $231,000 | -21.7% | 8,000 | +27.0% | 0.00% | – |
| Q4 2021 | $295,000 | +2.1% | 6,300 | -37.6% | 0.00% | – |
| Q4 2020 | $289,000 | -55.1% | 10,100 | -11.4% | 0.00% | -100.0% |
| Q3 2018 | $644,000 | -28.2% | 11,400 | -26.0% | 0.00% | 0.0% |
| Q2 2018 | $897,000 | 0.0% | 15,400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $897,000 | +7.3% | 15,400 | +18.7% | 0.00% | -33.3% |
| Q4 2017 | $836,000 | -38.6% | 12,978 | -55.0% | 0.00% | -50.0% |
| Q2 2017 | $1,362,000 | -37.8% | 28,854 | -34.5% | 0.01% | -50.0% |
| Q1 2017 | $2,188,000 | +534.2% | 44,065 | +673.9% | 0.01% | +500.0% |
| Q4 2016 | $345,000 | -87.3% | 5,694 | -88.2% | 0.00% | -86.7% |
| Q2 2016 | $2,719,000 | – | 48,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |